Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Multicentric Hospital-Based Surveillance of Pertussis Amongst Infants Admitted in Tertiary Care Facilities in India
A Apte1, R Shrivastava1, S Sanghavi1
1Department of Pediatrics, KEM Hospital Research Centre, Pune, India.
Insights
Pertussis (whooping cough) significantly burdens hospitalised infants in India, particularly younger, preterm, and unvaccinated infants. Immunisation is key to reducing this disease burden.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Pertussis poses a significant health threat to infants globally.
- Estimating the burden of pertussis in hospitalized infants is crucial for public health interventions in India.
Purpose of the Study:
- To determine the disease and economic burden of pertussis among hospitalized infants in India.
- To identify risk factors associated with pertussis infection in this population.
Main Methods:
- A multicenter hospital-based surveillance study was conducted.
- Infants with clinical suspicion of pertussis were recruited based on predefined criteria.
- Laboratory confirmation and economic impact assessment were performed.
Main Results:
- Out of 693 suspected infants, 32 (4.62%) had laboratory-confirmed pertussis.
- Common presentations included cough with emesis and pneumonia; apnea was associated with pertussis.
- Pertussis cases were younger, more likely preterm, and often inadequately immunized, incurring higher hospitalization costs.
Conclusions:
- Younger, preterm, and inadequately immunized infants are at higher risk for pertussis.
- Timely childhood immunization and maternal immunization are recommended to reduce pertussis burden.
- Pertussis significantly impacts healthcare costs and caregiver productivity.
Objective:
To estimate the disease and economic burden of pertussis amongst hospitalised infants in India.
Design:
Multicentric hospital-based surveillance study.
Participants:
Hospitalised infants with clinical suspicion of pertussis based on predefined criteria.
Outcome Measures:
Proportion of infants with laboratory-confirmed pertussis, economic burden of pertussis amongst hospitalised infants.
Results:
693 clinically suspected infants were recruited of which 32 (4.62%) infants had laboratory-confirmed pertussis. Progressive cough with post-tussive emesis (50%) and pneumonia (34%) were the common clinical presentations; apnea in young infants was significantly associated with pertussis. Infants with pertussis were more likely to be younger (median age 102.5 days vs.157 days) and born preterm (42.9% vs 24.5%). Almost 30% infants with pertussis had not received vaccine for pertussis with 50% of these infants aged less than 2 months. Pertussis was associated with higher costs of hospitalisation, pharmacy and loss of working days by caregivers as compared to non-pertussis cases.
Conclusions:
Younger infants, those born preterm and those inadequately immunised against pertussis are at higher risk of pertussis infection. Timely childhood immunisation and introduction of maternal immunisation for pertussis can help in reducing the disease burden.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment

